TrialAsian Pacific journal of cancer prevention : APJCP2024
Is There any Benefit of Addition of Neo-Adjuvant Chemotherapy (FOLFOX4) to Standard Preoperative Treatment of Rectal Cancer? A Randomized Clinical Trial.
Hanan Selim Mosallum et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.